ELEVANCE HEALTH INC (ELV) Stock Institutional Trading Activity
ELEVANCE HEALTH INC (ELV) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Brave Warrior Advisors, Eagle Capital Management, Baupost Group, Vulcan Value Partners, and Yacktman Asset Management. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.
Explore more:
- ELEVANCE HEALTH INC (ELV) stock institutional ownership
- ELEVANCE HEALTH INC (ELV) stock insider trading activity
- Stock rankings
| Portfolio quarter | Name | Type | Quantity | Remaining | Reported stock balance |
|---|---|---|---|---|---|
| Q3 2019 | TCI Fund Management | Buy | 1,068,512 | 4,080,597 | $979,751 |
| Q2 2019 | Yacktman Asset Management | Sell | -4,691 | 741,333 | $209,212 |
| Q2 2019 | Sequoia Financial Advisors | Sell | -112 | 805 | $227 |
| Q2 2019 | Hancock Classic Value | Sell | -423 | 2,407 | $679 |
| Q2 2019 | Vulcan Value Partners | Buy | 1,173,981 | 1,174,036 | $331,325 |
| Q2 2019 | TCI Fund Management | Buy | 3,012,085 | 3,012,085 | $850,041 |
| Q2 2019 | Viking Global Investors | Sell | -996,880 | 5,198,006 | $1,466,929 |
| Q1 2019 | Dodge & Cox Stock Fund | Sell | -200 | 1,200 | $344 |
| Q1 2019 | Yacktman Asset Management | Sell | -1,813 | 746,024 | $214,094 |
| Q1 2019 | Vulcan Value Partners | Sell | -2 | 55 | $16 |
| Q1 2019 | Sequoia Financial Advisors | Buy | 80 | 917 | $263 |
| Q1 2019 | Hancock Classic Value | Buy | 2,830 | 2,830 | $812 |
| Q1 2019 | Renaissance Technologies LLC | Buy | 248,173 | 275,973 | $79,199 |
| Q1 2019 | Egerton Capital UK | Buy | 443,428 | 694,185 | $199,217 |
| Q1 2019 | First Eagle U.S. Value | Sell | -622,658 | 1,837,393 | $527,295 |
| Q1 2019 | Viking Global Investors | Buy | 1,096,639 | 6,194,886 | $1,777,808 |
| Q4 2018 | Yacktman Asset Management | Sell | -71,315 | 747,837 | $196,404 |
| Q4 2018 | Vulcan Value Partners | Sell | -177 | 57 | $15 |
| Q4 2018 | Sequoia Financial Advisors | Sell | -31 | 837 | $220 |
| Q4 2018 | Renaissance Technologies LLC | Sell | -605,473 | 27,800 | $7,301 |
| Q4 2018 | Egerton Capital UK | Buy | 250,757 | 250,757 | $65,856 |
| Q4 2018 | First Eagle U.S. Value | Sell | -492,060 | 2,460,051 | $646,083 |
| Q4 2018 | Viking Global Investors | Buy | 315,448 | 5,098,247 | $1,338,953 |
| Q3 2018 | Yacktman Asset Management | Sell | -1,904 | 819,152 | $224,489 |
| Q3 2018 | Vulcan Value Partners | Sell | -635,959 | 234 | $64 |
| Q3 2018 | Sequoia Financial Advisors | Sell | -52 | 868 | $238 |
| Q3 2018 | First Eagle U.S. Value | Sell | -89,143 | 2,952,111 | $809,026 |
| Q3 2018 | Viking Global Investors | Buy | 328,029 | 4,782,799 | $1,310,726 |
| Q2 2018 | Yacktman Asset Management | Sell | -5,617 | 821,056 | $195,436 |
| Q2 2018 | Sequoia Financial Advisors | Buy | 920 | 920 | $219 |
Frequently asked questions about ELV activity
Which institutional owners are buying ELV?
Institutional owners buying ELV include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in ELV activity?
"Buy" means an investor increased their reported position in ELV compared to the prior reporting period. This reflects growing exposure to ELEVANCE HEALTH INC (ELV) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in ELV increasing?
Institutional interest in ELV can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.